Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Hepatitis

Predictive value of hepatitis B serological indicators for mortality among cancer survivors and validation in a gastric cancer cohort

Yangyu Zhang, Linlin Qu, Yuchen Pan, Yanhua Wu, Jing Jiang

published 27 Dec 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Hepatitis B vaccination status and knowledge, attitude, and practice towards Hepatitis B virus among medical sciences students: A cross-sectional study

Ibrahim A. Naqid, Ahmed A. Mosa, Shah Vahel Ibrahim, Nizar Hussein Ibrahim, Nawfal R. Hussein

published 06 Nov 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Maternal and neonatal outcomes in patients with hepatitis C and intrahepatic cholestasis of pregnancy: The sum of the parts

Emily C. Goins, Lauren E. Wein, Virginia Y. Watkins, Alexa I. K. Campbell, R. Phillips Heine, Brenna L. Hughes, Sarah K. Dotters-Katz, Jerome Jeffrey Federspiel

published 18 Oct 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Stationary distribution of a reaction-diffusion hepatitis B virus infection model driven by the Ornstein-Uhlenbeck process

Zhenyu Zhang, Guizhen Liang, Kangkang Chang

published 29 Sep 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Population genetic testing and SERPINA1 sequencing identifies unidentified alpha-1 antitrypsin deficiency alleles and gene-environment interaction with hepatitis C infection

Bryce A. Schuler, Lisa Bastarache, Janey Wang, Jing He, Sara L. Van Driest, Joshua C. Denny

published 31 Aug 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes

Michael Schwarz, Caroline Schwarz, Lukas Burghart, Nikolaus Pfisterer, David Bauer, Wolfgang Hübl, Mattias Mandorfer, Michael Gschwantler, Thomas Reiberger

published 24 Aug 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Differential impacts of vaccine scandal by ethnic and socioeconomic factors: Evidence from China

Mengna Luan, Qi Qi, Wenjing Shi, Zhigang Tao, Ying Bao, Jiushun Zhou

published 19 Jul 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda

Yunia Mayanja, Wasima Rida, Joshua Kimani, Ali Ssetala, Juliet Mpendo, Annet Nanvubya, Gaudensia Mutua, Omu Anzala, Matt A. Price

published 17 Jul 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Molecular diagnosis of patients with hepatitis A virus infection using amplicon-based nanopore sequencing

Geum-Young Lee, Kyungmin Park, Young-Sun Lee, Ji Hoon Kim, Kwan Soo Byun, Jongwoo Kim, Won-Keun Kim, Jin-Won Song

published 12 Jul 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Reduced protective efficacy of hepatitis B vaccine among fully vaccinated children in Ethiopia

Adane Adugna, Gebereselassie Demeke, Milkiyas Toru, Dareskedar Tsehay, Ahmed Esmael, Adane Mihret, Andargachew Mulu

published 07 Jul 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Sex differences in hepatitis A incidence rates–a multi-year pooled-analysis based on national data from nine high-income countries

Manfred S. Green, Naama Schwartz, Victoria Peer

published 13 Jun 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Effector memory CD8 T-cells as a novel peripheral blood biomarker for activated T-cell pediatric acute liver failure

Catherine A. Chapin, Thomas M. Burn, Tamir Diamond, Kathleen M. Loomes, Estella M. Alonso, Edward M. Behrens

published 02 Jun 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial)

Ashish Awasthi, Harshita Katiyar, Sumit Rungta, Amar Deep, Vinod Kumar, Shalimar, Ajay Kumar, Prachi Tiwari, Amit Goel

published 18 May 2023

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Hepatitis

You can change these options by clicking profile then "Alerts and Notifications"